Ayita Ray
Interventional Cardiology · Morehead, KYNPI 1154847945
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,967 of the $8,920 with a category attached, or 78.1%. It is spread thinly across 33 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,680 and has fallen 63.2% since, to $985 in 2025. That places this record below the midpoint for interventional cardiology clinicians in KY, where the typical reported total is $7,951.
Across 298 payments — averaging $29.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- AstraZeneca$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$935
- Amgen$893
- Novartis$626
- E.r. Squibb & Sons, L.L.C.$594
- plus $3K from 27 others
What the payments were for
- Grants$1,53917%
- Food & beverage$6,96778%
- Education$4145%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $1,433 |
| AstraZeneca(2 entities) | 44 | $1,106 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 46 | $935 |
| Amgen | 33 | $893 |
| Novartis | 29 | $626 |
| E.r. Squibb & Sons, L.L.C. | 25 | $594 |
| Johnson & Johnson | 18 | $510 |
| Medtronic(2 entities) | 8 | $380 |
| Boehringer Ingelheim | 17 | $351 |
| Pfizer | 13 | $259 |
| Novo Nordisk | 7 | $255 |
| Abiomed | 4 | $243 |
| Abbott | 4 | $168 |
| Cook Incorporated | 1 | $141 |
| Penumbra, Inc. | 2 | $124 |
| Amarin Pharma, Inc. | 6 | $117 |
| Merck | 6 | $101 |
| Lexicon Pharmaceuticals, Inc. | 4 | $82 |
| Bayer | 4 | $79 |
| Chiesi USA, Inc. | 1 | $72 |
| Scpharmaceuticals Inc. | 3 | $67 |
| Kestra Medical Technology Services, Inc. | 2 | $67 |
| Atricure, Inc. | 4 | $67 |
| Cvrx, Inc. | 2 | $44 |
| Shire North American Group Inc | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Viiv Healthcare Company | 1 | $21 |
| GE HealthCare | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONYX FRONTIER$238
- Repatha$125
- CAMZYOS$121
- LOKELMA$116
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$106
How this compares
$8,920 in reported general payments places this provider in the 50th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 44 | $234 |
| Atorvastatin Calcium | 38 | $202 |
| Nitroglycerin | 19 | $123 |
| Amlodipine Besylate | 18 | $57 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Morehead
- Mansha KahloonMorehead$14K
- Amit SrivastavaEdgewood$642K
- Avichai EresLexington$616K
- Steve LinLexington$362K
- Daniel StewartLouisville$290K
- Robert SawyerLexington$249K
- Ganesh Keshav ThirunavukkarasuLexington$220K
- Daniel RothschildLouisville$154K
- Naresh SolankhiLouisville$132K
- Ashish RastogiOwensboro$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.